Straumann Group shareholders approve all proposals and elect Xiaoqun Clever-Steg and Stefan Meister as new Board Members – Biotech Investments

Basel, 12 April 2024 – Today at the Annual General Meeting (AGM) of Straumann Holding AG, the Straumann shareholders approved all the proposals put forward by the Board of Directors by a large majority. The meeting was attended by 265 shareholders, who together with the independent voting representative, represented 70.6% of the total share capital.

The shareholders approved the following:

• The management report, the annual financial statements, and the consolidated financial statements for the 2023 business year
• The compensation report for the 2023 business year, in a consultative vote
• The non-financial report for the 2023 business year, in a consultative vote
• The fixed compensation of the Board of Directors collectively for the next term
• The compensation of the Executive Management
• The appropriation of earnings and the dividend payment for the 2023 business year of CHF 0.85 per share. The dividend is paid as follows: CHF 64 million (CHF 0.40 per share) out of capital contribution reserves and about CHF 72 million (CHF 0.45 per share) out of retained earnings, leaving a balance of approximately CHF 1.7 billion to be carried forward. After the deduction of 35% Swiss withholding tax, the dividend paid out net will be CHF 0.69 per share. The dividend will be paid out as of 18 April 2024. The ex-dividend date is 16 April 2024.
• Discharge of the Board of Directors and the Executive Management for the 2023 business year
• The election of Petra Rumpf as Member and Chair of the Board, as well as the re-election of Olivier Filliol, Marco Gadola, Thomas Straumann, and Regula Wallimann as Board Members – each for a term of one year.
• The election of Xiaoqun Clever-Steg and Stefan Meister as new Board Members
• Gilbert Achermann, Juan José Gonzalez and Nadia Tarolli Schmidt decided not to stand for re-election. On behalf of the shareholders and the company, the Board thanked them for their commitment and wished them all the best for the future. Thomas Straumann and Petra Rumpf thanked in particular Gilbert Achermann for more than 25 years of dedication to the company.
• The re-election of Regula Wallimann and Marco Gadola and the election of Olivier Filliol to the Human Resources & Compensation Committee for a term of one year
• The re-election of Neovius AG in Basel as the independent voting representative for a term of one year
• The re-election of Ernst & Young AG, Basel, as auditors for the 2024 business year

The voting results are attached to this release.

The next ordinary general meeting of Straumann’s shareholders will be convened on 10 April 2025 at the Basel Congress Center.

About Straumann Group

Straumann Holding AG, Peter Merian-Weg 12, 4002 Basel, Switzerland   

 Phone: +41 (0)61 965 11 11

Homepage: www.straumann-group.com

Contacts:

Disclaimer

This release contains forward-looking statements that reflect the current views of management, and which are subject to known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements of the Straumann Group to differ materially from those expressed or implied in this document. Statements are made on the basis of management’s views and assumptions regarding future events and business performance at the time the statements are made. They are subject to risks and uncertainties including, but not confined to, future global economic conditions, pandemics, exchange rates, legal provisions, market conditions, activities by competitors and other factors outside Straumann’s control. Should one or more of these risks or uncertainties materialize or should underlying assumptions prove incorrect, actual outcomes may vary materially from those forecasted or expected. Straumann is providing the information in this release as of this date and does not undertake any obligation to update any statements contained in it as a result of new information, future events or otherwise.  This release constitutes neither an offer to sell nor a solicitation to buy any securities.